Experimental gene therapy offers hope for rare brain disease in toddlers

NCT ID NCT04998396

First seen Apr 25, 2026 · Last updated Apr 25, 2026

Summary

This study tests a new gene therapy called BBP-812 for children with Canavan disease, a rare genetic disorder that damages the brain. The treatment uses a harmless virus to deliver a working copy of the missing gene. The trial aims to see if it is safe and can improve motor and thinking skills in up to 26 children under 30 months old.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANAVAN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Massachusetts General Hospital (MGH); Center for Rare Neurological Diseases (CRND)

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • UCSF Benioff Children's Hospital Oakland

    RECRUITING

    Oakland, California, 94609, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Weill Cornell Medicine; Division of Pediatric Neurology

    COMPLETED

    New York, New York, 10065, United States

Conditions

Explore the condition pages connected to this study.